TransMedics (TMDX) EBIT Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -559.00 |
| Dec 31, 2025 | -297.00 |
| Sep 30, 2025 | -704.00 |
| Jun 30, 2025 | 412.00 |
| Mar 31, 2025 | 1,201.00 |
| Dec 31, 2024 | 350.00 |
| Sep 30, 2024 | -734.00 |
| Jun 30, 2024 | -188.00 |
| Mar 31, 2024 | 962.00 |
| Dec 31, 2023 | 4,586.00 |
| Sep 30, 2023 | -4,093.00 |
| Jun 30, 2023 | 330.00 |
| Mar 31, 2023 | 1,658.00 |
| Dec 31, 2022 | -2.00 |
| Sep 30, 2022 | 2,590.00 |
| Jun 30, 2022 | 1,151.00 |
| Mar 31, 2022 | 5,817.00 |
| Dec 31, 2021 | 9,944.00 |
| Sep 30, 2021 | -10,275.00 |
| Jun 30, 2021 | -2,160.00 |
| Mar 31, 2021 | -1,495.00 |
| Dec 31, 2020 | -1,948.00 |
| Sep 30, 2020 | 17,400.00 |
| Jun 30, 2020 | -13,456.00 |
| Mar 31, 2020 | 4,628.00 |
| Dec 28, 2019 | -4,302.00 |
| Sep 28, 2019 | 3,547.00 |
| Jun 29, 2019 | -848.00 |
| Mar 30, 2019 | 5,198.00 |
| Dec 29, 2018 | -8,196.00 |
| Sep 29, 2018 | 7,935.00 |
| Jun 30, 2018 | 1,292.00 |